NEWS
Mayne earnings outlook rosy despite threat of Trump tariffs
MELBOURNE: Drugmaker Mayne Pharma, which is the subject of a $672m foreign takeover bid, has… read more
14 new senior healthcare executives sought for key roles
MELBOURNE: Fourteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
Heart device maker wins FDA approval in major corporate boost
SYDNEY: EBR Systems, the heart device hopeful heavily backed by high-profile investors including, private equity… read more
Chemist billionaire in $297m Sigma selldown bolsters ASX turnover
MELBOURNE: Damien Gance, a director of Sigma Health and Chemist Warehouse co-founder Sam Gance’s son,… read more
